证券记录 · 已归档季度
MYGN
Myriad Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
19被追踪持有人
0Δ持有人
56.51M持有股份
$408.57M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -3.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 966.11K | $4.16M | n/a | n/a |
| Q2 2026 | 84 | -5 | 70.39M | $401.85M | +6 | −11 |
| Q1 2026 | 92 | -3 | 73.19M | $329.45M | +3 | −6 |
| Q4 2025 | 95 | 0 | 80.50M | $495.06M | n/a | n/a |
| Q3 2025 | 19 | 0 | 56.51M | $408.57M | n/a | n/a |
| Q2 2025 | 16 | 0 | 51.45M | $273.22M | +1 | −1 |
| Q1 2025 | 13 | 0 | 25.12M | $222.86M | +1 | −1 |
| Q4 2024 | 13 | -1 | 27.01M | $370.33M | n/a | −1 |
| Q3 2024 | 13 | +3 | 18.94M | $518.67M | +3 | n/a |
| Q2 2024 | 10 | n/a | 22.76M | $556.69M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 14.88M | -1.3% | $107.58M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 7.88M | -14.8% | $56.99M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 4.98M | +3.5% | $35.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 4.75M | -3.6% | $34.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 5 | Glenview Capital ✦ | 4.59M | 0.0% | $33.17M | 0.8% | Held | 6 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 4.56M | +1.1% | $32.96M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 3.62M | n/a | $26.15M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 8 | Geode Capital Management ✦ (被动) | 2.23M | +0.1% | $16.09M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Goldman Sachs Group ✦ | 2.15M | n/a | $15.56M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | AQR Capital Management ✦ | 1.60M | +50.8% | $11.55M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 11 | Fisher Asset Management ✦ | 1.28M | -1.2% | $9.25M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 1.10M | n/a | $7.99M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 13 | Point72 Asset Management ✦ | 1.07M | +99.6% | $7.76M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 728.67K | +33.8% | $5.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 572.15K | -66.6% | $4.14M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Fidelity (FMR) ✦ | 398.23K | +14.2% | $2.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 17 | T. Rowe Price ✦ | 60.27K | +9.2% | $436,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Marshall Wace ✦ | 47.70K | -29.9% | $344,849 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 19 | Renaissance Technologies ✦ | 21.67K | -95.2% | $156,703 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 200 持有人, 87.60M 股份, $371.14M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 04
SC 13G: BlackRock Portfolio Management LLC
Aug 14
SC 13G/A: GLENVIEW CAPITAL MANAGEMENT, LLC
Aug 14
SC 13G: Vestal Point Capital, LP
Aug 07
SC 13G: STATE STREET CORP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据